Anaptysbio (ANAB) Return on Invested Capital (2018 - 2025)
Historic Return on Invested Capital for Anaptysbio (ANAB) over the last 6 years, with Q3 2025 value amounting to 0.77%.
- Anaptysbio's Return on Invested Capital rose 39000.0% to 0.77% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.77%, marking a year-over-year increase of 39000.0%. This contributed to the annual value of 1.45% for FY2024, which is 5100.0% down from last year.
- Latest data reveals that Anaptysbio reported Return on Invested Capital of 0.77% as of Q3 2025, which was up 39000.0% from 16.09% recorded in Q2 2025.
- Anaptysbio's 5-year Return on Invested Capital high stood at 16.09% for Q2 2025, and its period low was 5.63% during Q2 2024.
- Moreover, its 3-year median value for Return on Invested Capital was 1.75% (2023), whereas its average is 0.09%.
- Its Return on Invested Capital has fluctuated over the past 5 years, first skyrocketed by 1000bps in 2024, then skyrocketed by 217200bps in 2025.
- Quarter analysis of 3 years shows Anaptysbio's Return on Invested Capital stood at 1.58% in 2023, then increased by 6bps to 1.48% in 2024, then skyrocketed by 152bps to 0.77% in 2025.
- Its last three reported values are 0.77% in Q3 2025, 16.09% for Q2 2025, and 1.91% during Q1 2025.